Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells

Regulatory Peptides

Volumn 188, Issue , 2014, Pages 5-12

  Klironomos, Stefanos ^a   Notas, George ^a   Sfakianaki, Ourania ^a   Kiagiadaki, Foteini ^a   Xidakis, Costas ^a   Kouroumalis, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Fibrosis; Hepatic stellate cells; Procollagen; Somatostatin; Somatostatin receptors

Indexed keywords

ALPHA1 PROCOLLAGEN; OCTREOTIDE; PHOSPHATASE; PHOSPHOSERINE; PHOSPHOTHREONINE; PHOSPHOTYROSINE; PLATELET DERIVED GROWTH FACTOR; PROCOLLAGEN; SOMATOSTATIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME INHIBITION; INHIBITION KINETICS; LIVER FIBROSIS; MALE; NONHUMAN; PRIMARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL;

FIBROSIS; HEPATIC STELLATE CELLS; PROCOLLAGEN; SOMATOSTATIN; SOMATOSTATIN RECEPTORS;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; HEPATIC STELLATE CELLS; LIVER; LIVER CIRRHOSIS; MALE; OCTREOTIDE; PHOSPHOPROTEINS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TYROSINE PHOSPHATASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84890813076     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.11.002     Document Type: Article

References (60)

1. Bonacchi A., Romagnani P., Romanelli R.G., Efsen E., Annunziato F., Lasagni L., Francalanci M., Serio M., Laffi G., Pinzani M., Gentilini P., Marra F. Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 2001, 276:9945-9954.
2. Brenner D.A. Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc 2009, 120:361-368.
3. Galli A., Crabb D.W., Ceni E., Salzano R., Mello T., Svegliati-Baroni G., Ridolfi F., Trozzi L., Surrenti C., Casini A. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002, 122:1924-1940.
4. Friedman S.L., Maher J.J., Bissell D.M. Mechanisms and therapy of hepatic fibrosis: report of the AASLD single topic basic research conference. Hepatology 2000, 32:1403-1408.
5. Rockey D.C., Boyles J.K., Gabbiani G., Friedman S.L. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992, 24:193-203.
6. Rockey D.C. Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis 2001, 21:337-349.
7. Marra F., Romanelli R.G., Giannini C., Failli P., Pastacaldi S., Arrighi M.C., Pinzani M., Laffi G., Montalto P., Gentilini P. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999, 29:140-148.
8. Kinnman N., Hultcrantz R., Barbu V., Rey C., Wendum D., Poupon R., Housset C. PDGF-mediated chemoattraction of hepatic stellate cells by bile duct segments in cholestatic liver injury. Lab Invest 2000, 80:697-707.
9. Rockey D.C. The cell and molecular biology of hepatic fibrogenesis. Clinical and therapeutic implications. Clin Liver Dis 2000, 4:319-355.
10. Arthur M.J., Fibrogenesis I.I. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2000, 279:G245-G249.
11. Takahara T., Furui K., Funaki J., Nakayama Y., Itoh H., Miyabayashi C., Sato H., Seiki M., Ooshima A., Watanabe A. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 1995, 21:787-795.
12. Benyon R.C., Iredale J.P., Goddard S., Winwood P.J., Arthur M.J. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996, 110:821-831.
13. Hellerbrand C., Stefanovic B., Giordano F., Burchardt E.R., Brenner D.A. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 1999, 30:77-87.
14. Pinzani M., Gesualdo L., Sabbah G.M., Abboud H.E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989, 84:1786-1793.
15. Pinzani M. PDGF and signal transduction in hepatic stellate cells. Front Biosci 2002, 7:d1720-d1726.
16. Gallois C., Habib A., Tao J., Moulin S., Maclouf J., Mallat A., Lotersztajn S. Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem 1998, 273:23183-23190.
17. Saile B., Matthes N., Knittel T., Ramadori G. Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology 1999, 30:196-202.
18. Zhou L., Yan C., Gieling R.G., Kida Y., Garner W., Li W., Han Y.P. Tumor necrosis factor-alpha induced expression of matrix metalloproteinase-9 through p21-activated kinase-1. BMC Immunol 2009, 10:15.
19. Hernandez-Munoz I., de la Torre P., Sanchez-Alcazar J.A., Garcia I., Santiago E., Munoz-Yague M.T., Solis-Herruzo J.A. Tumor necrosis factor alpha inhibits collagen alpha 1(I) gene expression in rat hepatic stellate cells through a G protein. Gastroenterology 1997, 113:625-640.
20. Houglum K., Buck M., Kim D.J., Chojkier M. TNF-alpha inhibits liver collagen-alpha 1(I) gene expression through a tissue-specific regulatory region. Am J Physiol 1998, 274:G840-G847.
21. Manning D.S., Afdhal N.H. Diagnosis and quantitation of fibrosis. Gastroenterology 2008, 134:1670-1681.
22. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
23. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008, 88:125-172.
24. Bataller R., Brenner D.A. Liver fibrosis. J Clin Invest 2005, 115:209-218.
25. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007, 117:539-548.
26. Saile B., DiRocco P., Dudas J., El-Armouche H., Sebb H., Eisenbach C., Neubauer K., Ramadori G. IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF). Lab Invest 2004, 84:1037-1049.
27. Vanetti M., Kouba M., Wang X., Vogt G., Hollt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett 1992, 311:290-294.
28. Schindler M., Holloway S., Hathway G., Woolf C.J., Humphrey P.P., Emson P.C. Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception. Brain Res 1998, 798:25-35.
29. Patel Y.C. Somatostatin and its receptor family. Front Neuroendocrinol 1999, 20:157-198.
30. Patel Y.C. Molecular pharmacology of somatostatin receptor subtypes. J Endocrinol Invest 1997, 20:348-367.
31. Valatas V., Kolios G., Manousou P., Xidakis C., Notas G., Ljumovic D., Kouroumalis E.A. Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotide. Regul Pept 2004, 120:215-225.
32. Xidakis C., Ljumovic D., Manousou P., Notas G., Valatas V., Kolios G., Kouroumalis E. Production of pro- and anti-fibrotic agents by rat Kupffer cells; the effect of octreotide. Dig Dis Sci 2005, 50:935-941.
33. Valatas V., Xidakis C., Roumpaki H., Kolios G., Kouroumalis E.A. Isolation of rat Kupffer cells: a combined methodology for highly purified primary cultures. Cell Biol Int 2003, 27:67-73.
34. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
35. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
36. Schulz S., Handel M., Schreff M., Schmidt H., Hollt V. Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J Physiol Paris 2000, 94:259-264.
37. Schulz S., Schmitt J., Wiborny D., Schmidt H., Olbricht S., Weise W., Roessner A., Gramsch C., Hollt V. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Cancer Res 1998, 4:2047-2052.
38. Pan Q., Li D.G., Lu H.M., Lu L.Y., You H.N., Xu Q.F. Relationship between somatostatin receptors and activation of hepatic stellate cells. Chin Med J (Engl) 2004, 117:1665-1669.
39. Reynaert H., Vaeyens F., Qin H., Hellemans K., Chatterjee N., Winand D., Quartier E., Schuit F., Urbain D., Kumar U., Patel Y.C., Geerts A. Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology 2001, 121:915-930.
40. Song S.H., Leng X.S., Li T., Qin Z.Z., Peng J.R., Zhao L., Wei Y.H., Yu X. Expression of subtypes of somatostatin receptors in hepatic stellate cells. World J Gastroenterol 2004, 10:1663-1665.
41. Song S.H., Leng X.S., Li T., Peng J.R., Zhao L., Qin Z.Z., Wei Y.H., Yu X. The effect of somatostatin analogue on expression of connective tissue growth factor gene of rat hepatic stellate cells. Zhonghua Wai Ke Za Zhi 2004, 42:551-553.
42. Lang A., Sakhnini E., Fidder H.H., Maor Y., Bar-Meir S., Chowers Y. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells. Liver Int 2005, 25:808-816.
43. Reynaert H., Rombouts K., Jia Y., Urbain D., Chatterjee N., Uyama N., Geerts A. Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol 2005, 146:77-88.
44. Borie R., Fabre A., Prost F., Marchal-Somme J., Lebtahi R., Marchand-Adam S., Aubier M., Soler P., Crestani B. Activation of somatostatin receptors attenuates pulmonary fibrosis. Thorax 2008, 63:251-258.
45. Pan Q., Li D.G., Lu H.M., Lu L.Y., Wang Y.Q., Xu Q.F. Antiproliferative and proapoptotic effects of somatostatin on activated hepatic stellate cells. World J Gastroenterol 2004, 10:1015-1018.
46. Pinzani M., Milani S., Herbst H., DeFranco R., Grappone C., Gentilini A., Caligiuri A., Pellegrini G., Ngo D.V., Romanelli R.G., Gentilini P. Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996, 148:785-800.
47. Wong L., Yamasaki G., Johnson R.J., Friedman S.L. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 1994, 94:1563-1569.
48. Kinnman N., Goria O., Wendum D., Gendron M.C., Rey C., Poupon R., Housset C. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury. Lab Invest 2001, 81:1709-1716.
49. Turkcapar N., Bayar S., Koyuncu A., Ceyhan K. Octreotide inhibits hepatic fibrosis, bile duct proliferation and bacterial translocation in obstructive jaundice. Hepatogastroenterology 2003, 50:680-683.
50. Tracy T.F., Tector A.J., Goerke M.E., Kitchen S., Lagunoff D. Somatostatin analogue (octreotide) inhibits bile duct epithelial cell proliferation and fibrosis after extrahepatic biliary obstruction. Am J Pathol 1993, 143:1574-1578.
51. Wang Z.R., Li D.G., Chen X.M., Huang X., Wei H.S., Wang Y.Q., Xu Q.F., Lu H.M. Therapeutic effects of octreotide on hepatofibrosis-induced with carbon tetrachloride in rats. Zhonghua Gan Zang Bing Za Zhi 2003, 11:408-411.
52. Fort J., Oberti F., Pilette C., Veal N., Gallois Y., Douay O., Rousselet M.C., Rosenbaum J., Cales P. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology 1998, 28:1525-1531.
53. De Minicis S., Seki E., Uchinami H., Kluwe J., Zhang Y., Brenner D.A., Schwabe R.F. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007, 132:1937-1946.
54. Colas B., Cambillau C., Buscail L., Zeggari M., Esteve J.P., Lautre V., Thomas F., Vaysse N., Susini C. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Eur J Biochem 1992, 207:1017-1024.
55. Lopez F., Esteve J.P., Buscail L., Delesque N., Saint-Laurent N., Vaysse N., Susini C. Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphatase. Metabolism 1996, 45:14-16.
56. Buscail L., Esteve J.P., Saint-Laurent N., Bertrand V., Reisine T., O'Carroll A.M., Bell G.I., Schally A.V., Vaysse N., Susini C. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci U S A 1995, 92:1580-1584.
57. Ferjoux G., Lopez F., Esteve J.P., Ferrand A., Vivier E., Vely F., Saint-Laurent N., Pradayrol L., Buscail L., Susini C. Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. Mol Biol Cell 2003, 14:3911-3928.
58. Wang L., Wang X., Chen J., Yang Z., Yu L., Hu L., Shen X. Activation of protein serine/threonine phosphatase PP2Calpha efficiently prevents liver fibrosis. PLoS One 2010, 5:e14230.
59. Yamashita M., Dimayuga P., Kaul S., Shah P.K., Regnstrom J., Nilsson J., Cercek B. Phosphatase activity in the arterial wall after balloon injury: effect of somatostatin analog octreotide. Lab Invest 1999, 79:935-944.
60. Florio T., Thellung S., Arena S., Corsaro A., Bajetto A., Schettini G., Stork P.J. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2. J Physiol Paris 2000, 94:239-250.